GoHealth, Inc. (GOCO)
NASDAQ: GOCO · IEX Real-Time Price · USD
19.74
+0.29 (1.49%)
At close:
Jun 2, 2023, 4:00 PM
19.16
-0.58 (-2.94%)
After-hours:
Jun 2, 2023, 5:19 PM EDT
GoHealth Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for GoHealth stock is $11.25, which predicts a decrease of -43.01%. The lowest target is 8.50 and the highest is 14. On average, analysts rate GoHealth stock as a sell.
Analyst Consensus: Sell
* Price targets were last updated on Apr 4, 2023.
Analyst Ratings
The average analyst rating for GoHealth stock from 2 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 1 | 1 | 1 |
| Sell | 3 | 3 | 3 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
800.43M
from 631.68M
Increased by
26.72%
Revenue Next Year
883.41M
from 800.43M
Increased by
10.37%
EPS This Year
-5.00
from -17.72
EPS Next Year
-2.51
from -5.00
| Year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 877.35M | 1.06B | 631.68M | 800.43M | 883.41M |
| Revenue Growth | - | 21.09% | -40.54% | 26.72% | 10.37% |
| EPS | -3.35 | -26.80 | -17.72 | -5.00 | -2.51 |
| EPS Growth | - | - | - | - | - |
| No. Analysts | - | - | - | 6 | 6 |
Revenue Forecast
| Revenue | 2023 | 2024 |
|---|---|---|
| High | 840.7M | 943.6M |
| Avg | 800.4M | 883.4M |
| Low | 735.4M | 793.3M |
Revenue Growth
| Revenue Growth | 2023 | 2024 |
|---|---|---|
| High | 33.1%
| 17.9%
|
| Avg | 26.7%
| 10.4%
|
| Low | 16.4%
| -0.9%
|
EPS Forecast
| EPS | 2023 | 2024 |
|---|---|---|
| High | -4.84 | 3.29 |
| Avg | -5.00 | -2.51 |
| Low | -5.09 | -4.75 |
EPS Growth
| EPS Growth | 2023 | 2024 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.